![Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-020-0073-9/MediaObjects/41573_2020_73_Fig1_HTML.png)
Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery
![α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1 | Journal of Nuclear Medicine α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1 | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/59/6/878/F1.large.jpg?width=800&height=600&carousel=1)
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1 | Journal of Nuclear Medicine
![Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy | Semantic Scholar Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/da68a54f03082921f215e9dd7cb523b4fbe6f461/2-Figure1-1.png)
Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy | Semantic Scholar
![Molecules | Free Full-Text | Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators Molecules | Free Full-Text | Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators](https://pub.mdpi-res.com/molecules/molecules-23-00581/article_deploy/html/images/molecules-23-00581-g005.png?1569905828)
Molecules | Free Full-Text | Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators
![α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1 | Journal of Nuclear Medicine α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1 | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/59/6/878/F3.large.jpg)
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1 | Journal of Nuclear Medicine
![213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience | SpringerLink 213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-014-2857-9/MediaObjects/259_2014_2857_Fig1_HTML.gif)
213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience | SpringerLink
![Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches | Cancer Biotherapy and Radiopharmaceuticals Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches | Cancer Biotherapy and Radiopharmaceuticals](https://www.liebertpub.com/cms/10.1089/cbr.2018.2494/asset/images/medium/figure1.gif)